SynthesisMethods in molecular biology (Clifton, N.J.)2021
Leverage Large-Scale Biological Networks to Decipher the Genetic Basis of Human Diseases Using Machine Learning.
Synthesis in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- Screening of early-staged colorectal neoplasia by clonal hematopoiesis-based liquid biopsy and machine-learning.American journal of cancer research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
A fundamental question in precision medicine is to quantitatively decode the genetic basis of complex human diseases, which will enable the development of predictive models of disease risks based on personal genome sequences. To account for the complex systems within different cellular contexts, large-scale regulatory networks are critical components to be integrated into the analysis. Based on the fast accumulation of multiomics and disease genetics data, advanced machine learning algorithms and efficient computational tools are becoming the driving force in predicting phenotypes from genotypes, identifying potential causal genetic variants, and revealing disease mechanisms. Here, we review the state-of-the-art methods for this topic and describe a computational pipeline that assembles a series of algorithms together to achieve improved disease genetics prediction through the delineation of regulatory circuitry step by step.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.